Vertex Pharmaceuticals Incorporated Reviews Corporate Strategy And Outlines Key 2014 Business Priorities At The 32nd Annual J.P. Morgan Healthcare Conference
Published: Jan 13, 2014
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today outlined key 2014 business priorities aimed at supporting investment in future opportunities in cystic fibrosis (CF) and other high-potential research and development programs. Jeffrey Leiden, M.D., Ph.D., Chair, President and Chief Executive Officer of Vertex, will discuss the company's corporate strategy and 2014 business priorities as part of a webcast presentation at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14 at 8:30 a.m. PT (11:30 a.m. ET).
Help employers find you! Check out all the jobs and post your resume.